Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set

Publication

Release Date: 11 Nov 2011

Topic: Alcohol & other drug treatment services

Media release

AIHW

Australian Institute of Health and Welfare (2011) Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set, AIHW, Australian Government, accessed 12 September 2024.

APA

Australian Institute of Health and Welfare. (2011). Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set. Canberra: AIHW.

MLA

Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set. AIHW, 2011.

Vancouver

Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set. Canberra: AIHW; 2011.

Harvard

Australian Institute of Health and Welfare 2011, Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set, AIHW, Canberra.

PDF | 2.7Mb

Other formats

Download publication

Around 170,000 treatment episodes for alcohol and other drug use were provided in Australia in 2009-10. Almost half were for treatment related to alcohol use-the highest proportion observed since the collection began in 2001. As with previous years, counselling was the most common type of treatment offered. One in ten episodes involved more than one type of treatment.

ISSN: 1447-6746
ISBN: 978-1-74249-224-7
Cat. no: HSE 114
Pages: 150

Preliminary material: Acknowledgments; Abbreviations; Symbols

A summary of alcohol and other drug treatment in 2009–10

1 Introduction

Definitions of terms used in this report
1.1 How are the data collected?
1.2 What's included?
- 1.2.1 Agencies and clients included
- 1.2.2 Agencies and clients excluded
1.3 Important issues that explain the data
- 1.3.1 Clients are not counted
- 1.3.2 Funding source cannot be differentiated
- 1.3.3 Covering of Indigenous substance use services is limited
- 1.3.4 Implementation makes a difference
1.4 Data issues specific to the 2009–10 year
1.5 Explanatory notes

2 Treatment agencies–what sector and where are the treatment agencies?

2.1 Service sector
2.2 Locations
2.3 Treatment types reporting from different geographical locations

3 Clients – who uses alcohol and other drug treatment services?

3.1 Own or other's drug use
- 3.1.1 Across Australia
- 3.1.2 Age and sex
3.2 Indigenous Australians
- 3.2.1 Indigenous clients in the AODTS-NMDS collection
- 3.2.2 Care provided by OATSIH-funded substance use-specific services
3.3 Country of birth and preferred language

4 Drugs of concern–what drugs do people seek treatment for?

4.1 Principal drugs of concern
- 4.1.1 Principal drugs of concern across Australia
- 4.1.2 Principal drugs of concern over time
- 4.1.3 Age and principal drug of concern
- 4.1.4 Sex and principal drugs of concern
- 4.1.5 Indigenous Australians and principal drug of concern
4.2 Individual principal drug of concern profiles
- 4.2.1 Alcohol
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
- 4.2.2 Cannabis
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
- 4.2.3 Heroin
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
- 4.2.4 Amphetamines
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
- 4.2.5 Benzodiazepines
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
- 4.2.6 Ecstasy
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
- 4.2.7 Cocaine
  - Patterns of use in Australia
  - Drug profile
  - Client profile
  - Treatment profile
4.3 All drugs of concern

5 Treatment – what treatments do people receive?

5.1 Main treatment
- 5.1.1 Main treatment types across Australia
- 5.1.2 Main treatment types over time
- 5.1.3 Aboriginal and Torres Strait Islander people and treatment programs
- 5.1.4 Reasons for leaving treatment
5.2 Specific main treatment types
- 5.2.1 Counselling
  - Principal drug profile
  - Client profile
  - Treatment profile
- 5.2.2 Withdrawal management (detoxification)
  - Principal drug profile
  - Client profile
  - Treatment profile
- 5.2.3 Assessment only
  - Principal drug profile
  - Client profile
  - Treatment profile
- 5.2.4 Information and education only
  - Principal drug profile
  - Client profile
  - Treatment profile
- 5.2.5 Support and case management only
  - Principal drug profile
  - Client profile
  - Treatment profile
- 5.2.6 Rehabilitation
  - Principal drug profile
  - Client profile
  - Treatment profile
- 5.2.7 Other main treatment types
  - Principal drug profile
  - Client profile
  - Treatment profile
5.3 Additional treatments
5.4 National Opioid Pharmacotherapy Statistics Annual Data Collection 2010
- 5.4.1 Number of clients receiving pharmacotherapy treatment
5.5 Opioid pharmacotherapy treatment in prison health services 2010

6 Hospital treatment – what drug-related diagnoses do people go to hospital for?

6.1 Drug-related hospital separations in 2009–10
- 6.1.1 Drugs associated with hospital separations
- 6.1.2 Hospital separations by sex
- 6.1.3
- 6.1.3 Hospital separations by age
- 6.1.4 Hospital separations by socioeconomic status
- 6.1.5 Hospital separations among Indigenous Australians
- 6.1.6 Public versus private hospitals
6.2 Hospital separation trends

7 Collection methods and data quality – how are the data collected?

7.1 Collection method and data included
7.2 Comprehensiveness of the data
- 7.2.1 Australian Government data
- 7.2.2 Data quality
7.3 Policy and administrative features in each jurisdiction
7.4 Data quality considerations for other collections

Appendix 1: About the collection

Responsibility for the collection
Government health authorities
Alcohol and other drug treatment agencies
AIHW
Using AODTS–NMDS Data

Appendix 2: Data elements in the AODTS NMDS for 2009–10

Appendix 3: Detailed tables

Agency tables
Client profile tables
Drugs of concern tables
Treatment program tables
Hospital separation tables

Appendix 4: Australian Standard Geographical Classification

Appendix 5: Australian Standard Classification of Drugs of Concern (ASCDC)

1 Analgesics
- 11 Organic Opiate Analgesics
- 12 Semisynthetic Opioid Analgesics
- 13 Synthetic Opioid Analgesics
- 14 Non Opioid Analgesics
2 Sedatives and hypnotics
- 21 Alcohols
- 22 Anaesthetics
- 23 Barbiturates
- 24 Benzodiazepines
- 29 Other Sedatives and Hypnotics
3 Stimulants and hallucinogens
- 31 Amphetamines
- 32 Cannabinoids
- 33 Ephedra Alkaloids
- 34 Phenethylamines
- 35 Tryptamines
- 36 Volatile Nitrates
- 39 Other Stimulants and Hallucinogens
4 Anabolic agents and selected hormones
- 41 Anabolic Androgenic Steroids
- 42 Beta Agonists
- 43 Peptide Hormones, Mimetics and Analogues
- 49 Other Anabolic Agents and Selected Hormones
5 Antidepressants and antipsychotics
- 51 Monoamine Oxidase Inhibitors
- 52 Phenothiazines
- 53 Serotonin Reuptake Inhibitors
- 54 Thioxanthenes
- 55 Tricyclic Antidepressants
- 59 Other Antidepressants and Antipsychotics
6 Volatile solvents
- 61 Aliphatic Hydrocarbons
- 62 Aromatic Hydrocarbons
- 63 Halogenated Hydrocarbons
- 69 Other Volatile Solvents
9 Miscellaneous drugs of concern
- 91 Diuretics
- 92 Opioid Antagonists
- 99 Other Drugs of Concern

Appendix 6: Alcohol and other drug treatment provided by services funded to assist Aboriginal and Torres Strait Islander people

Substance use-specific services
Substance use treatment and assistance
- Substances as a specifically targeted program
- Substances on an individual client basis

Appendix 7: Mapping of ICD-10-AM codes to ASCDC output categories

End matter: References; List of tables; List of figures; List of boxes